<?xml version='1.0' encoding='utf-8'?>
<document id="32103133"><sentence text="Development and validation of UPLC-MS/MS method for studying the pharmacokinetic interaction of dasabuvir and tamoxifen, 4-hydroxytamoxifen in Wistar rats."><entity charOffset="96-105" id="DDI-PubMed.32103133.s1.e0" text="dasabuvir" /><entity charOffset="110-119" id="DDI-PubMed.32103133.s1.e1" text="tamoxifen" /><entity charOffset="121-139" id="DDI-PubMed.32103133.s1.e2" text="4-hydroxytamoxifen" /><pair ddi="false" e1="DDI-PubMed.32103133.s1.e0" e2="DDI-PubMed.32103133.s1.e0" /><pair ddi="false" e1="DDI-PubMed.32103133.s1.e0" e2="DDI-PubMed.32103133.s1.e1" /><pair ddi="false" e1="DDI-PubMed.32103133.s1.e0" e2="DDI-PubMed.32103133.s1.e2" /><pair ddi="false" e1="DDI-PubMed.32103133.s1.e1" e2="DDI-PubMed.32103133.s1.e1" /><pair ddi="false" e1="DDI-PubMed.32103133.s1.e1" e2="DDI-PubMed.32103133.s1.e2" /></sentence><sentence text="Hepatitis C virus (HCV) is the main cause of chronic hepatitis and probably liver cirrhosis" /><sentence text=" Dasabuvir (DSV) is a direct-acting antiviral agent with efficiency in managing HCV"><entity charOffset="1-10" id="DDI-PubMed.32103133.s3.e0" text="Dasabuvir" /><entity charOffset="12-15" id="DDI-PubMed.32103133.s3.e1" text="DSV" /><pair ddi="false" e1="DDI-PubMed.32103133.s3.e0" e2="DDI-PubMed.32103133.s3.e0" /><pair ddi="false" e1="DDI-PubMed.32103133.s3.e0" e2="DDI-PubMed.32103133.s3.e1" /></sentence><sentence text=" The anti-viral activity of the anti-estrogen drug tamoxifen (TAM) suggested the synergistic effect of DSV and TAM for blocking the replication of HCV"><entity charOffset="51-60" id="DDI-PubMed.32103133.s4.e0" text="tamoxifen" /><entity charOffset="62-65" id="DDI-PubMed.32103133.s4.e1" text="TAM" /><entity charOffset="103-105" id="DDI-PubMed.32103133.s4.e2" text="DSV" /><entity charOffset="111-113" id="DDI-PubMed.32103133.s4.e3" text="TAM" /><pair ddi="false" e1="DDI-PubMed.32103133.s4.e0" e2="DDI-PubMed.32103133.s4.e0" /><pair ddi="false" e1="DDI-PubMed.32103133.s4.e0" e2="DDI-PubMed.32103133.s4.e1" /><pair ddi="false" e1="DDI-PubMed.32103133.s4.e0" e2="DDI-PubMed.32103133.s4.e2" /><pair ddi="false" e1="DDI-PubMed.32103133.s4.e0" e2="DDI-PubMed.32103133.s4.e3" /><pair ddi="false" e1="DDI-PubMed.32103133.s4.e1" e2="DDI-PubMed.32103133.s4.e1" /><pair ddi="false" e1="DDI-PubMed.32103133.s4.e1" e2="DDI-PubMed.32103133.s4.e2" /><pair ddi="false" e1="DDI-PubMed.32103133.s4.e1" e2="DDI-PubMed.32103133.s4.e3" /><pair ddi="false" e1="DDI-PubMed.32103133.s4.e2" e2="DDI-PubMed.32103133.s4.e2" /><pair ddi="false" e1="DDI-PubMed.32103133.s4.e2" e2="DDI-PubMed.32103133.s4.e3" /></sentence><sentence text=" However, being substrates and inhibitors of efflux transporters (TAM inhibits P-gp, DSV inhibits P-gp and BCRP), there is a possibility for a pharmacokinetic (PK) drug-drug interaction"><entity charOffset="85-87" id="DDI-PubMed.32103133.s5.e0" text="DSV" /><entity charOffset="66-68" id="DDI-PubMed.32103133.s5.e1" text="TAM" /><pair ddi="false" e1="DDI-PubMed.32103133.s5.e1" e2="DDI-PubMed.32103133.s5.e1" /><pair ddi="false" e1="DDI-PubMed.32103133.s5.e1" e2="DDI-PubMed.32103133.s5.e0" /></sentence><sentence text=" In this work, a new UPLC-MS/MS method was developed and validated for the simultaneous determination of TAM, its active metabolite 4-hydroxy tamoxifen (TOH), and DSV in rat plasma"><entity charOffset="132-151" id="DDI-PubMed.32103133.s6.e0" text="4-hydroxy tamoxifen" /><entity charOffset="153-156" id="DDI-PubMed.32103133.s6.e1" text="TOH" /><entity charOffset="163-166" id="DDI-PubMed.32103133.s6.e2" text="DSV" /><entity charOffset="105-107" id="DDI-PubMed.32103133.s6.e3" text="TAM" /><pair ddi="false" e1="DDI-PubMed.32103133.s6.e3" e2="DDI-PubMed.32103133.s6.e3" /><pair ddi="false" e1="DDI-PubMed.32103133.s6.e3" e2="DDI-PubMed.32103133.s6.e0" /><pair ddi="false" e1="DDI-PubMed.32103133.s6.e3" e2="DDI-PubMed.32103133.s6.e1" /><pair ddi="false" e1="DDI-PubMed.32103133.s6.e3" e2="DDI-PubMed.32103133.s6.e2" /><pair ddi="false" e1="DDI-PubMed.32103133.s6.e0" e2="DDI-PubMed.32103133.s6.e0" /><pair ddi="false" e1="DDI-PubMed.32103133.s6.e0" e2="DDI-PubMed.32103133.s6.e1" /><pair ddi="false" e1="DDI-PubMed.32103133.s6.e0" e2="DDI-PubMed.32103133.s6.e2" /><pair ddi="false" e1="DDI-PubMed.32103133.s6.e1" e2="DDI-PubMed.32103133.s6.e1" /><pair ddi="false" e1="DDI-PubMed.32103133.s6.e1" e2="DDI-PubMed.32103133.s6.e2" /></sentence><sentence text=" The method was applied to investigate the PK interaction between DSV and TAM/TOH following the co-administration of DSV and TAM to Wistar rats"><entity charOffset="66-68" id="DDI-PubMed.32103133.s7.e0" text="DSV" /><entity charOffset="117-119" id="DDI-PubMed.32103133.s7.e1" text="DSV" /><entity charOffset="74-76" id="DDI-PubMed.32103133.s7.e2" text="TAM" /><entity charOffset="125-127" id="DDI-PubMed.32103133.s7.e3" text="TAM" /><entity charOffset="78-80" id="DDI-PubMed.32103133.s7.e4" text="TOH" /><pair ddi="false" e1="DDI-PubMed.32103133.s7.e0" e2="DDI-PubMed.32103133.s7.e0" /><pair ddi="false" e1="DDI-PubMed.32103133.s7.e0" e2="DDI-PubMed.32103133.s7.e2" /><pair ddi="false" e1="DDI-PubMed.32103133.s7.e0" e2="DDI-PubMed.32103133.s7.e4" /><pair ddi="false" e1="DDI-PubMed.32103133.s7.e0" e2="DDI-PubMed.32103133.s7.e1" /><pair ddi="false" e1="DDI-PubMed.32103133.s7.e0" e2="DDI-PubMed.32103133.s7.e3" /><pair ddi="false" e1="DDI-PubMed.32103133.s7.e2" e2="DDI-PubMed.32103133.s7.e2" /><pair ddi="false" e1="DDI-PubMed.32103133.s7.e2" e2="DDI-PubMed.32103133.s7.e4" /><pair ddi="false" e1="DDI-PubMed.32103133.s7.e2" e2="DDI-PubMed.32103133.s7.e1" /><pair ddi="false" e1="DDI-PubMed.32103133.s7.e2" e2="DDI-PubMed.32103133.s7.e3" /><pair ddi="false" e1="DDI-PubMed.32103133.s7.e4" e2="DDI-PubMed.32103133.s7.e4" /><pair ddi="false" e1="DDI-PubMed.32103133.s7.e4" e2="DDI-PubMed.32103133.s7.e1" /><pair ddi="false" e1="DDI-PubMed.32103133.s7.e4" e2="DDI-PubMed.32103133.s7.e3" /><pair ddi="false" e1="DDI-PubMed.32103133.s7.e1" e2="DDI-PubMed.32103133.s7.e1" /><pair ddi="false" e1="DDI-PubMed.32103133.s7.e1" e2="DDI-PubMed.32103133.s7.e3" /></sentence><sentence text=" Chromatographic analysis was performed on Waters BEHTM C18 column using a mobile phase of acetonitrile/water containing 0"><entity charOffset="91-103" id="DDI-PubMed.32103133.s8.e0" text="acetonitrile" /></sentence><sentence text="1% formic acid (80: 20, v/v)"><entity charOffset="3-14" id="DDI-PubMed.32103133.s9.e0" text="formic acid" /></sentence><sentence text=" The method allowed the determination of concentration ranges 20-1000, 0" /><sentence text="1-500, 0" /><sentence text="5-500â€‰ng/mL for DSV, TAM, and TOH, respectively"><entity charOffset="16-26" id="DDI-PubMed.32103133.s12.e0" text="DSV" /><entity charOffset="21-31" id="DDI-PubMed.32103133.s12.e1" text="TAM" /><entity charOffset="30-40" id="DDI-PubMed.32103133.s12.e2" text="TOH" /><pair ddi="false" e1="DDI-PubMed.32103133.s12.e0" e2="DDI-PubMed.32103133.s12.e0" /><pair ddi="false" e1="DDI-PubMed.32103133.s12.e0" e2="DDI-PubMed.32103133.s12.e1" /><pair ddi="false" e1="DDI-PubMed.32103133.s12.e0" e2="DDI-PubMed.32103133.s12.e2" /><pair ddi="false" e1="DDI-PubMed.32103133.s12.e1" e2="DDI-PubMed.32103133.s12.e1" /><pair ddi="false" e1="DDI-PubMed.32103133.s12.e1" e2="DDI-PubMed.32103133.s12.e2" /></sentence><sentence text=" Unexpectedly, results revealed the absence of PK interactions between DSV and TAM/TOH, compared with their single administration, suggesting the safety of co-administering DSV/TAM as an anti-viral combination without the need of dosage adjustment"><entity charOffset="83-86" id="DDI-PubMed.32103133.s13.e0" text="TOH" /><entity charOffset="71-73" id="DDI-PubMed.32103133.s13.e1" text="DSV" /><entity charOffset="173-175" id="DDI-PubMed.32103133.s13.e2" text="DSV" /><entity charOffset="79-81" id="DDI-PubMed.32103133.s13.e3" text="TAM" /><entity charOffset="177-179" id="DDI-PubMed.32103133.s13.e4" text="TAM" /><pair ddi="false" e1="DDI-PubMed.32103133.s13.e1" e2="DDI-PubMed.32103133.s13.e1" /><pair ddi="false" e1="DDI-PubMed.32103133.s13.e1" e2="DDI-PubMed.32103133.s13.e3" /><pair ddi="false" e1="DDI-PubMed.32103133.s13.e1" e2="DDI-PubMed.32103133.s13.e0" /><pair ddi="false" e1="DDI-PubMed.32103133.s13.e1" e2="DDI-PubMed.32103133.s13.e2" /><pair ddi="false" e1="DDI-PubMed.32103133.s13.e1" e2="DDI-PubMed.32103133.s13.e4" /><pair ddi="false" e1="DDI-PubMed.32103133.s13.e3" e2="DDI-PubMed.32103133.s13.e3" /><pair ddi="false" e1="DDI-PubMed.32103133.s13.e3" e2="DDI-PubMed.32103133.s13.e0" /><pair ddi="false" e1="DDI-PubMed.32103133.s13.e3" e2="DDI-PubMed.32103133.s13.e2" /><pair ddi="false" e1="DDI-PubMed.32103133.s13.e3" e2="DDI-PubMed.32103133.s13.e4" /><pair ddi="false" e1="DDI-PubMed.32103133.s13.e0" e2="DDI-PubMed.32103133.s13.e0" /><pair ddi="false" e1="DDI-PubMed.32103133.s13.e0" e2="DDI-PubMed.32103133.s13.e2" /><pair ddi="false" e1="DDI-PubMed.32103133.s13.e0" e2="DDI-PubMed.32103133.s13.e4" /><pair ddi="false" e1="DDI-PubMed.32103133.s13.e2" e2="DDI-PubMed.32103133.s13.e2" /><pair ddi="false" e1="DDI-PubMed.32103133.s13.e2" e2="DDI-PubMed.32103133.s13.e4" /></sentence><sentence text="" /></document>